This article reviewed the therapeutic use of chitosan as artificial lacrima, medical viscoelastic material, carrier of drug delivery systems and so on in ophthalmic disease.
本文就壳聚泪液、医用粘弹剂、药物缓释系统载体、抗纤维增生药物等的应用进行
要的介绍。
This article reviewed the therapeutic use of chitosan as artificial lacrima, medical viscoelastic material, carrier of drug delivery systems and so on in ophthalmic disease.
本文就壳聚泪液、医用粘弹剂、药物缓释系统载体、抗纤维增生药物等的应用进行
要的介绍。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
This article reviewed the therapeutic use of chitosan as artificial lacrima, medical viscoelastic material, carrier of drug delivery systems and so on in ophthalmic disease.
本文就壳聚糖泪液、医用粘弹剂、药物缓释系统载体、抗纤维增生药物等的应用进行
要的介绍。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
This article reviewed the therapeutic use of chitosan as artificial lacrima, medical viscoelastic material, carrier of drug delivery systems and so on in ophthalmic disease.
就壳聚糖作为人工泪液、医用粘弹剂、药物缓释系统载体、抗纤维增生药物等的应用进行
要的介绍。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表亦不代表
软件的观点;若发现问题,欢迎向我们指正。
This article reviewed the therapeutic use of chitosan as artificial lacrima, medical viscoelastic material, carrier of drug delivery systems and so on in ophthalmic disease.
本文糖作为人工泪液、医用粘弹剂、药物缓释系统载体、抗纤维增生药物等的应用进行
要的介绍。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审,
达内容亦不代
本软件的观点;若发现问题,欢迎向我们指正。
This article reviewed the therapeutic use of chitosan as artificial lacrima, medical viscoelastic material, carrier of drug delivery systems and so on in ophthalmic disease.
本文就壳聚糖作为人工泪液、医用粘弹剂、药物缓释系统载体、增生药物等的应用进行
要的介绍。
声明:以上例句、词类均由互联网资源自动生成,部
未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
This article reviewed the therapeutic use of chitosan as artificial lacrima, medical viscoelastic material, carrier of drug delivery systems and so on in ophthalmic disease.
本文就壳聚糖作为人工泪液、医用粘弹剂、释系统载体、抗纤维增生
等的应用进行
要的介绍。
声明:以上例句、词性分类均由互联自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
This article reviewed the therapeutic use of chitosan as artificial lacrima, medical viscoelastic material, carrier of drug delivery systems and so on in ophthalmic disease.
本文就壳聚糖作为人工泪液、医用、药物缓释系统载体、抗纤维增
药物等的应用进行
要的介绍。
声明:以上例句、词性分类均由互联网资源成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
This article reviewed the therapeutic use of chitosan as artificial lacrima, medical viscoelastic material, carrier of drug delivery systems and so on in ophthalmic disease.
本文就壳聚糖作为人、医用粘弹剂、药物缓释系统载体、抗纤维增生药物等的应用进行
要的介绍。
声明:以上例句、词性类均由互联网资源自动生成,部
过人
审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
This article reviewed the therapeutic use of chitosan as artificial lacrima, medical viscoelastic material, carrier of drug delivery systems and so on in ophthalmic disease.
本文就壳聚糖作为人工泪液、医粘弹剂、药物缓释系统载体、抗纤维增生药物等
进行
要
。
明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件
观点;若发现问题,欢迎向我们指正。